Navigation Links
Amylin Pharmaceuticals Announces Time Change to Previously Announced Presentation at the Morgan Stanley Global Healthcare Unplugged Conference
Date:4/30/2008

SAN DIEGO, April 30 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today announced it has re-scheduled its presentation time at the Morgan Stanley Global Healthcare Unplugged Conference in Key Biscayne, FL to Thursday, May 1, 2008 at 3:00 p.m. ET / 12:00 p.m. PT. Previously, the presentation had been scheduled for 9:20 a.m. ET / 6:20 a.m. PT. Daniel M. Bradbury, President and Chief Executive Officer of Amylin Pharmaceuticals, will be providing a corporate overview.

The live presentation and breakout session will be webcast, and a recording will be made available following the event. The webcast and recording will be accessible through Amylin's corporate website, located at http://www.amylin.com. To access the live webcast, please log on to Amylin's site approximately fifteen minutes prior to the presentation to register and download any necessary audio software.

About Amylin Pharmaceuticals

Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN(R) (pramlintide acetate) injection and BYETTA(R) (exenatide) injection. Amylin's research and development activities leverage the company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is headquartered in San Diego, California with over 1,900 employees nationwide. Further information on Amylin Pharmaceuticals is available at http://www.amylin.com.


'/>"/>
SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Amylin Pharmaceuticals to Present at Morgan Stanley Global Healthcare Unplugged Conference
2. Amylin Pharmaceuticals to Webcast First Quarter Results
3. Amylin Pharmaceuticals to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
4. Amylin Pharmaceuticals to Present at Nasdaq 20th Investor Program
5. Xenome Receives a Syndicated US$10 Million Equity Investment from Queensland BioCapital Fund, Amylin Pharmaceuticals and Innovis Investment Partners
6. Amylin Pharmaceuticals Elects Adrian Adams to Board of Directors
7. Amylin Pharmaceuticals to Present at BIOCOM Investor Conference
8. Amylin Pharmaceuticals Reports Third Quarter Financial Results
9. Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIGs Plenary Panel in Vegas
10. Amylin Pharmaceuticals to Present at BioCentury NewsMakers Conference, Thomas Weisel Healthcare Conference and Bear Stearns Healthcare Conference
11. Anadys Pharmaceuticals Reports First Quarter 2008 Financial Results and Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... 2014  Orexigen Therapeutics, Inc. (Nasdaq: OREX ... List of Outstanding Issues (LOI) from the European Medicines ... for the NB32 Marketing Authorization Application (MAA). NB32 (naltrexone ... drug candidate being evaluated for weight loss. ... point were adequately addressed by the Company based in ...
(Date:7/30/2014)... July 30, 2014 Researchers often use ... biology, but such devices can do much more ... As such, researchers have looked to patterned assemblies ... metabolic engineering to characterize – and potentially ... devices are envisioned to recreate animal and human ...
(Date:7/30/2014)... 2014  AtheroNova Inc. (OTCBB: AHRO), a biotech ... compounds to safely regress atherosclerotic plaque and improve ... partner, CardioNova, has accomplished first dosing of subjects ... lead compound, AHRO-001.  This Phase 1b trial will ... safety trial completed in February 2014, in which ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 NCERC ... Athmanathan will present his findings on corn stover ... conference this week in Washington, D.C. , ... Energy conference is a testament to the success ... Caupert said. “Thanks to the foresight and vision ...
Breaking Biology Technology:Orexigen Receives CHMP Day 180 List of Outstanding Issues 2Orexigen Receives CHMP Day 180 List of Outstanding Issues 3UMD Researchers Bridge Gap between Microelectronics, Biological Systems 2UMD Researchers Bridge Gap between Microelectronics, Biological Systems 3UMD Researchers Bridge Gap between Microelectronics, Biological Systems 4AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001 2AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001 3AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001 4NCERC at SIUE Researcher Takes Stage at Department of Energy Conference 2NCERC at SIUE Researcher Takes Stage at Department of Energy Conference 3
... HILL, England, September 1 , With some ... to start the,new school year, new guidance from ... looks set to revolutionise the way children,manage their ... by greater access to insulin pump therapy. The ...
... treatment of HIV-positive individuals with American Biotech ... improvement in the condition of the subjects after ... nanosilver particles can block entry of the ... ALPINE, UT, Aug. 29 /PRNewswire-FirstCall/ - American Biotech ...
... Corporation,(Nasdaq: PARS ) today announced that effective ... Israel, and manage those activities currently,based in Rehovot ... New,Jersey., The research programs in Israel are ... development of PRS-639,058 for,neuropathic pain. Additionally the Company ...
Cached Biology Technology:British School Kids With Diabetes Gain First Time Freedom From Injections With New Insulin Pump Guidelines 2British School Kids With Diabetes Gain First Time Freedom From Injections With New Insulin Pump Guidelines 3British School Kids With Diabetes Gain First Time Freedom From Injections With New Insulin Pump Guidelines 4Preliminary Report of American Biotech Labs HIV Study Featured in Inaugural Issue of Journal of the Science of Healing Outcomes 2Pharmos Corporation Announces That it Will Cease Operations in Israel 2
(Date:7/30/2014)... changing climate threaten some of the world,s most ... establish seed collections to save the seeds in ... some genetic diversity., For decades, these seed collections ... a one-size-fits-all approach for how many seeds to ... regardless of species, pollination mode, growth habitat and ...
(Date:7/30/2014)... they eat, the Food and Drug Administration (FDA) earlier ... label found on nearly every food product in the ... (C&EN), the weekly news magazine of the American ... fight that has ensued. , Britt Erickson, a senior ... Facts label has remained largely the same for two ...
(Date:7/30/2014)... from Wayne State University,s College of Engineering recently ... Foundation for the project, "Nanoparticle-directed synthesis of organic ... Foundation, nanotechnology is the creation and utilization of ... and functions. A major bottleneck in scaling up ... connect different functional materials into one device. A ...
Breaking Biology News(10 mins):Saving seeds the right way can save the world's plants 2NSF grant to Wayne State supports new concept for manufacturing nanoscale devices 2
... amorous midshipman fish to the strains of a Puccini aria ... neural circuitry that led to the human love song not ... of vertebrates was likely laid down hundreds of millions of ... By mapping the developing brain cells in newly hatched midshipman fish ...
... for food service and salad mixes is an increasingly ... perishable, and the cutting required in processing further shortens ... fresh produce in semipermeable plastic films extends shelf life ... modified-atmosphere (MA) packaging for lettuce and certain salad greens ...
... joining forces to conceptualize, develop and bring to reality ... care through UC San Diego,s new Institute of Engineering ... to repair damaged hearts, and scarless surgery techniques are ... with the new Institute leading the way. "As ...
Cached Biology News:From humming fish to Puccini: Vocal communication evolved with ancient species 2Good breeding increases shelf life 2UC San Diego launches Institute of Engineering in Medicine to accelerate health care tech 2UC San Diego launches Institute of Engineering in Medicine to accelerate health care tech 3
...
... Western Blot Strong Antibody Stripping Solution is ... blots that have been developed with chemiluminescence ... is not recommended for stripping colorimetric substrates ... not possible to effectively remove substrates that ...
... Liquid. 100 ml supplied as a ... remove antibodies from membrane-bound proteins without ... stripping chemiluminescent or radioisotopic signals from ... Western blots. Supplied as a 5X ...
... is specifically designed for two-dimensional electrophoresis ... four proteins in this marker have ... pattern across a 2D gel. The ... Mol wt: 17,000-89,000 ...
Biology Products: